Needham & Company
-
Iterum Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference
-
Iterum Therapeutics (ITRM) PT Lowered to $7 at Needham & Company, Following Earnings
-
Iterum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
-
Iterum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
-
Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
-
Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
-
Needham & Company Starts Iterum Therapeutics (ITRM) at Buy
-
Iterum Therapeutics (ITRM) IPO Opens Modeslty Lower
-
Iterum Therapeutics plc (ITRM) Prices 6.15M Share IPO at $13/Sh
-
Iterum Therapeutics Announces Pricing of Initial Public Offering